For example, while IFNγ appears to be effective in treating adult T cell leukemia and ovarian cancers, it is relatively ineffective for most patients suffering from chronic myeloid leukemia [37]. Here, IFNG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.